#2009 Impact of systemic glucocorticoids on Gd-IgA1 levels in Immunoglobulin A Nephropathy: insights from the TESTING trial
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.0437
Abstract: Galactose-deficient IgA1 (Gd-IgA1) is a key player in the pathogenesis of Immunoglobulin A Nephropathy (IgAN), driving immune complex formation and subsequent kidney damage. The Therapeutic Effects of Steroids in IgA Nephropathy Global (TESTING) trial demonstrated… read more here.
Keywords: testing trial; total iga; iga1 levels; group ... See more keywords
IgA1 Glycosylation Is Heritable in Healthy Twins.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Society of Nephrology : JASN"
DOI: 10.1681/asn.2016020184
Abstract: IgA nephropathy (IgAN) is the most common form of primary GN and an important cause of kidney failure. Characteristically, patients with IgAN have increased serum levels of undergalactosylated IgA1 (gd-IgA1). To assess the degree to… read more here.
Keywords: iga1 glycosylation; serum iga1; iga1; serum ... See more keywords